Anna V. Starostina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anna V. Starostina has a total of 79 co-authors. Here are the top co-authors by number of shared publications:
- Alla V. Sidorova
The S. Fyodorov Eye Microsurgery Federal State Institution
6 shared publications A. V. Sidorova
S.N. Fyodorov Eye Microsurgery Federal State Institution of the Russian Ministry of Health
4 shared publications- Konstantin S. Burlakov
S. Fyodorov Eye Microsurgery Federal State Institution
4 shared publications - Margarita R. Khabazova
Federal Medico-Biological Agency Federal Research Clinical Center
4 shared publications - M.A. Eliseeva
S.N. Fedorov National Medical Research Center "MNTK "Eye Microsurgery", Moscow, Russia
3 shared publications - Oksana I. Markelova
Helmholtz National Medical Research Center of Eye Diseases
3 shared publications
Latest Publications
- 5 April 2026
- Published by Real Time, Ltd. in Russian Ophthalmological Journal
- Vol. 19 (1)
Brinzolamide/brimonidine fixed combination for open-angle glaucoma and ocular hypertension treatment: hypotensive efficacy and tolerability
The literature review analyzes the data of 12-year clinical use of a fixed combination of 1% brinzolamide and 0.2 % brimonidine (BBFC) in the treatment of glaucoma and ocular hypertension. This drug is an alternative for patients with systemic contraindications in the form of broncho-obstructive syndrome and cardiovascular pathology. The monotherapy BBFC hypotensive effect is 30 % of the IOP initial level and corresponds to that of brinzolamide/brimonidine non-fixed combination. Switching patients with glaucoma and ocular hypertension from monotherapy with brinzolamide or brimonidine to BBFC is accompanied by an additional hypotensive effect at the of 13% of the initial IOP. BBFC has a good additional hypotensive effect in combination with drugs of other pharmaceutical groups, and also effectively relieves the hypertension after laser capsulotomy, intravitreal anti-VEGF injections and phacoemulsification. The most common BBFC ophthalmological adverse effects are conjunctival hyperemia, conjunctivitis, allergic reactions and eye discomfort with a frequency of about 10–20 %.
- 5 April 2026
- Published by Real Time, Ltd. in Russian Ophthalmological Journal
- Vol. 19 (1)
Brinzolamide/brimonidine fixed combination for open-angle glaucoma and ocular hypertension treatment: hypotensive efficacy and tolerability
The literature review analyzes the data of 12-year clinical use of a fixed combination of 1% brinzolamide and 0.2 % brimonidine (BBFC) in the treatment of glaucoma and ocular hypertension. This drug is an alternative for patients with systemic contraindications in the form of broncho-obstructive syndrome and cardiovascular pathology. The monotherapy BBFC hypotensive effect is 30 % of the IOP initial level and corresponds to that of brinzolamide/brimonidine non-fixed combination. Switching patients with glaucoma and ocular hypertension from monotherapy with brinzolamide or brimonidine to BBFC is accompanied by an additional hypotensive effect at the of 13% of the initial IOP. BBFC has a good additional hypotensive effect in combination with drugs of other pharmaceutical groups, and also effectively relieves the hypertension after laser capsulotomy, intravitreal anti-VEGF injections and phacoemulsification. The most common BBFC ophthalmological adverse effects are conjunctival hyperemia, conjunctivitis, allergic reactions and eye discomfort with a frequency of about 10–20 %.
- Open Access
- 29 March 2026
- Published by PE Polunina Elizareta Gennadievna in Ophthalmology in Russia
- Vol. 23 (1) , 163-168
A case of Exudative Retinal Detachment after Fistulizing Antiglaucoma Surgery in a Patient with Sturge — Weber Syndrome
A clinical case of exudative retinal detachment after trabeculectomy for secondary glaucoma with Sturge-Weber syndrome is presented. A 50-year-old female patient with Sturge-Weber syndrome sought help for secondary glaucoma with elevated intraocular pressure on maximum drug hypotensive therapy. According to these indications, she was offered trabeculectomy with posterior trepanation of the sclera. Surgical treatment was without intraoperative complications. However, in the early postoperative period flat choroidal detachment and widespread retinal detachment involving the macular region were detected. During observation and prescription of anti-inflammatory and cycloplegic therapy, resolution of the exudative process was noted 1 month after surgery. Conclusion. Despite the peculiarities of the postoperative course, trabeculectomy is one of the effective methods of surgical treatment of secondary glaucoma in Sturge-Weber syndrome.
- 29 March 2026
- Published by PE Polunina Elizareta Gennadievna in Ophthalmology in Russia
- Vol. 23 (1) , 163-168
Open AccessA case of Exudative Retinal Detachment after Fistulizing Antiglaucoma Surgery in a Patient with Sturge — Weber Syndrome
A clinical case of exudative retinal detachment after trabeculectomy for secondary glaucoma with Sturge-Weber syndrome is presented. A 50-year-old female patient with Sturge-Weber syndrome sought help for secondary glaucoma with elevated intraocular pressure on maximum drug hypotensive therapy. According to these indications, she was offered trabeculectomy with posterior trepanation of the sclera. Surgical treatment was without intraoperative complications. However, in the early postoperative period flat choroidal detachment and widespread retinal detachment involving the macular region were detected. During observation and prescription of anti-inflammatory and cycloplegic therapy, resolution of the exudative process was noted 1 month after surgery. Conclusion. Despite the peculiarities of the postoperative course, trabeculectomy is one of the effective methods of surgical treatment of secondary glaucoma in Sturge-Weber syndrome.
- 10 February 2026
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 25 (3) , 1700-1713
Molecular Portraits of Aqueous Humor in Primary and Pseudoexfoliative Open-Angle Glaucoma
Glaucoma is a neurodegenerative disease that affects the optic nerve and retinal ganglion cells. The two most common forms, primary open-angle glaucoma (POAG) and pseudoexfoliative glaucoma (PEG), are associated with ocular hypertension caused by impaired aqueous humor (AH) outflow but have specific ocular and systemic features that may determine their diagnosis and treatment. To identify these features, we compared AH composition in patients using a multiomics approach. Total reflection X-ray fluorescence analysis revealed an increase in zinc and calcium concentrations more pronounced in PEG. Nuclear magnetic resonance study identified common metabolomic changes involving amino acids (Ala, Glu, His, Lys, Tre) and tricarboxylic acid cycle components (citrate and succinate). Targeted liquid chromatography-tandem mass spectrometry data demonstrated shared elevation of oxidative stress-related oxylipins (9/13-HODE, 9-HOTrE) and POAG-specific changes in phospholipase A2 products (DHA, lyso-PAF) and inflammatory prostaglandins (PGE2 and 15d-PGJ2). POAG featured secretion of proteins controlling intraocular pressure (angiotensinogen) and trabecular meshwork outflow (myocilin and cystatin C) and altered levels of neurotrophic factors (PEDF, VGF). Our data highlight novel AH biomarkers distinguishing POAG from PEG (15d-PGJ2, VGF) and demonstrate that they have specific triggers and responses to ocular hypertension but share common mechanisms, such as oxidative stress, mitochondrial dysfunction, and zinc and calcium toxicity.
- 10 February 2026
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 25 (3) , 1700-1713
Molecular Portraits of Aqueous Humor in Primary and Pseudoexfoliative Open-Angle Glaucoma
Glaucoma is a neurodegenerative disease that affects the optic nerve and retinal ganglion cells. The two most common forms, primary open-angle glaucoma (POAG) and pseudoexfoliative glaucoma (PEG), are associated with ocular hypertension caused by impaired aqueous humor (AH) outflow but have specific ocular and systemic features that may determine their diagnosis and treatment. To identify these features, we compared AH composition in patients using a multiomics approach. Total reflection X-ray fluorescence analysis revealed an increase in zinc and calcium concentrations more pronounced in PEG. Nuclear magnetic resonance study identified common metabolomic changes involving amino acids (Ala, Glu, His, Lys, Tre) and tricarboxylic acid cycle components (citrate and succinate). Targeted liquid chromatography-tandem mass spectrometry data demonstrated shared elevation of oxidative stress-related oxylipins (9/13-HODE, 9-HOTrE) and POAG-specific changes in phospholipase A2 products (DHA, lyso-PAF) and inflammatory prostaglandins (PGE2 and 15d-PGJ2). POAG featured secretion of proteins controlling intraocular pressure (angiotensinogen) and trabecular meshwork outflow (myocilin and cystatin C) and altered levels of neurotrophic factors (PEDF, VGF). Our data highlight novel AH biomarkers distinguishing POAG from PEG (15d-PGJ2, VGF) and demonstrate that they have specific triggers and responses to ocular hypertension but share common mechanisms, such as oxidative stress, mitochondrial dysfunction, and zinc and calcium toxicity.
- Open Access
- 9 January 2026
- Published by Real Time, Ltd. in Russian Ophthalmological Journal
- Vol. 18 (4) , 34-38
Early results of Preserflo MicroShunt implantation in primary open-angle glaucoma
Purpose: to evaluate the efficacy and safety of Preserflo MicroShunt implantation in patients with primary open-angle glaucoma (POAG) as the first and second glaucoma surgery in the early postoperative period. Material and methods. Single-center prospective non-randomized study of Preserflo MicroShunt implantation in 12 patients (12 eyes) aged 60,4 ± 17,8 with moderate and advanced POAG with an average IOP of 30.3 ± 9.1 mm Hg. IOP was determined at 1, 3, 7 days, 2 weeks, 1 and 3 months after surgery. Results. The IOP level was 10.2 ± 5.0, 9.4 ± 4.4, 11.3 ± 4.5, 10.8 ± 4.2, 12.7 ± 5.6 and 13.0 ± 6.1 mm Hg, respectively. Baseline average visual acuity was 0.5 ± 0.3, unchanged either on day 7 or by 3 month. Hypotony £ 6 mmHg was in 4 cases, with a flat anterior chamber and choroidal effusion without Seidel positive leakage in 2 cases, without anterior chamber reformation. In 5 cases, IOP increase required bleb needling filtration, and in 2 cases — the medication therapy restart. Conclusion. Preserflo MicroShunt implantation in patients with POAG is an effective and safe procedure for up to 3 months after surgery.
- 9 January 2026
- Published by Real Time, Ltd. in Russian Ophthalmological Journal
- Vol. 18 (4) , 34-38
Open AccessEarly results of Preserflo MicroShunt implantation in primary open-angle glaucoma
Purpose: to evaluate the efficacy and safety of Preserflo MicroShunt implantation in patients with primary open-angle glaucoma (POAG) as the first and second glaucoma surgery in the early postoperative period. Material and methods. Single-center prospective non-randomized study of Preserflo MicroShunt implantation in 12 patients (12 eyes) aged 60,4 ± 17,8 with moderate and advanced POAG with an average IOP of 30.3 ± 9.1 mm Hg. IOP was determined at 1, 3, 7 days, 2 weeks, 1 and 3 months after surgery. Results. The IOP level was 10.2 ± 5.0, 9.4 ± 4.4, 11.3 ± 4.5, 10.8 ± 4.2, 12.7 ± 5.6 and 13.0 ± 6.1 mm Hg, respectively. Baseline average visual acuity was 0.5 ± 0.3, unchanged either on day 7 or by 3 month. Hypotony £ 6 mmHg was in 4 cases, with a flat anterior chamber and choroidal effusion without Seidel positive leakage in 2 cases, without anterior chamber reformation. In 5 cases, IOP increase required bleb needling filtration, and in 2 cases — the medication therapy restart. Conclusion. Preserflo MicroShunt implantation in patients with POAG is an effective and safe procedure for up to 3 months after surgery.
- Open Access
- 30 December 2024
- Published by ECO-Vector LLC in Ophthalmology Reports
- Vol. 17 (4) , 67-75
Implantation of Ahmed drainage device in secondary “silicone” glaucoma. Features of the postoperative course
BACKGROUND: Despite the high technological effectiveness of treatment methods for vitreoretinal conditions, secondary glaucoma is a fairly common complication in the postoperative period, especially after tamponade with silicone oil. AIM: The aim of this study is to evaluate the effectiveness of Ahmed valve drainage device implantation in secondary glaucoma after vitreoretinal surgery with silicone oil tamponade and after the silicone oil removal. MATERIALS AND METHODS: The study included 42 patients with secondary glaucoma after vitreoretinal procedures with silicone oil tamponade for rhegmatogenous retinal detachment. Patients were divided into two groups: group 1 included 27 patients with avitria after silicone oil removal, group 2 — 15 patients with silicone oil tamponade in whom silicone oil removal was not indicated for various reasons. Before surgery, decompensation of intraocular pressure was detected in all patients (32.5 ± 2.9 mmHg, at the maximum hypotensive regimen), visual acuity varied from counting fingers to 0.5 with no correction of refractive error possible. RESULTS: In all cases, anti-glaucoma surgeries with Ahmed valve implantation were performed without complications. In the early postoperative period, the hypotensive effect was achieved in 100% of cases in both groups, the level of intraocular pressure on the first day after surgery in patients with avitria after removal of silicone oil averaged 9.3 ± 1.5 mmHg, in the group with silicone oil in the vitreal cavity — 10.2 ± 1.8 mmHg. The most common complication in the early postoperative period in patients with silicone oil tamponade was a shallow anterior chamber (in 40% of cases). Intraocular pressure was compensated in all patients within 12 months. CONCLUSIONS: The use of Ahmed drainage device is an effective method of intraocular pressure normalization in patients with secondary glaucoma after vitreoretinal procedures, both with silicone oil tamponade and avitria.
- 30 December 2024
- Published by ECO-Vector LLC in Ophthalmology Reports
- Vol. 17 (4) , 67-75
Open AccessImplantation of Ahmed drainage device in secondary “silicone” glaucoma. Features of the postoperative course
BACKGROUND: Despite the high technological effectiveness of treatment methods for vitreoretinal conditions, secondary glaucoma is a fairly common complication in the postoperative period, especially after tamponade with silicone oil. AIM: The aim of this study is to evaluate the effectiveness of Ahmed valve drainage device implantation in secondary glaucoma after vitreoretinal surgery with silicone oil tamponade and after the silicone oil removal. MATERIALS AND METHODS: The study included 42 patients with secondary glaucoma after vitreoretinal procedures with silicone oil tamponade for rhegmatogenous retinal detachment. Patients were divided into two groups: group 1 included 27 patients with avitria after silicone oil removal, group 2 — 15 patients with silicone oil tamponade in whom silicone oil removal was not indicated for various reasons. Before surgery, decompensation of intraocular pressure was detected in all patients (32.5 ± 2.9 mmHg, at the maximum hypotensive regimen), visual acuity varied from counting fingers to 0.5 with no correction of refractive error possible. RESULTS: In all cases, anti-glaucoma surgeries with Ahmed valve implantation were performed without complications. In the early postoperative period, the hypotensive effect was achieved in 100% of cases in both groups, the level of intraocular pressure on the first day after surgery in patients with avitria after removal of silicone oil averaged 9.3 ± 1.5 mmHg, in the group with silicone oil in the vitreal cavity — 10.2 ± 1.8 mmHg. The most common complication in the early postoperative period in patients with silicone oil tamponade was a shallow anterior chamber (in 40% of cases). Intraocular pressure was compensated in all patients within 12 months. CONCLUSIONS: The use of Ahmed drainage device is an effective method of intraocular pressure normalization in patients with secondary glaucoma after vitreoretinal procedures, both with silicone oil tamponade and avitria.
- Open Access
- 12 December 2024
- Published by Research Institute of Eye Diseases in National Journal glaucoma
- Vol. 23 (4) , 29-35
Micropulse laser cyclophotocoagulation in the treatment of secondary glaucoma in patients with post-burn and terminal dystrophic corneal leukoma as a stage of preparation for keratoprosthesis surgery
PURPOSE. To evaluate the effectiveness of micropulse laser cyclophotocoagulation (mCPC) in patients with secondary glaucoma associated with post-burn and terminal dystrophic corneal leukomas.METHODS. Twelve patients (12 eyes) with corneal leukomas and secondary glaucoma underwent mCPC. The mean age of the patients was 44±6.5 years, including 8 men and 4 women. All patients exhibited elevated intraocular pressure (IOP), ranging from Tpalp "+" to Tpalp "++," despite being on maximum combination hypotensive therapy. Visual acuity for all patients was 1/∞ light perception with correct projection (proectia lucis certa).RESULTS. On the first postoperative day, IOP was reduced to Tpalp "+" in 4 patients and to Tpalp "N" in 8 patients. Hypotensive therapy was continued based on individual indications throughout the observation period. By day 7, IOP had decreased to Tpalp "N" in all patients and remained stable throughout the follow-up period. Visual acuity in all cases remained unchanged from the preoperative level. Ultrasound biomicroscopy (UBM) revealed that the mean ciliary body thickness (CBT) before surgery was 0.56±0.11 mm. On the first postoperative day, CBT increased by an average of 20.1% due to pronounced edema caused by hydration from the inflammatory response, with a gradual return to baseline by the 1-month follow-up. At 6 months, no statistically significant difference in CBT from the preoperative thickness was observed, with a mean CBT of 0.50±0.12 mm.CONCLUSIONS. Micropulse cyclophotocoagulation can be an effective treatment for secondary glaucoma in patients with post-burn and terminal dystrophic corneal leukomas. This technique reduces the risk of intraoperative and postoperative complications due to its non-invasive nature and low surgical trauma. The procedure can be repeated if IOP increases, and gentle laser parameters can help preserve visual potential.
- 12 December 2024
- Published by Research Institute of Eye Diseases in National Journal glaucoma
- Vol. 23 (4) , 29-35
Open AccessMicropulse laser cyclophotocoagulation in the treatment of secondary glaucoma in patients with post-burn and terminal dystrophic corneal leukoma as a stage of preparation for keratoprosthesis surgery
PURPOSE. To evaluate the effectiveness of micropulse laser cyclophotocoagulation (mCPC) in patients with secondary glaucoma associated with post-burn and terminal dystrophic corneal leukomas.METHODS. Twelve patients (12 eyes) with corneal leukomas and secondary glaucoma underwent mCPC. The mean age of the patients was 44±6.5 years, including 8 men and 4 women. All patients exhibited elevated intraocular pressure (IOP), ranging from Tpalp "+" to Tpalp "++," despite being on maximum combination hypotensive therapy. Visual acuity for all patients was 1/∞ light perception with correct projection (proectia lucis certa).RESULTS. On the first postoperative day, IOP was reduced to Tpalp "+" in 4 patients and to Tpalp "N" in 8 patients. Hypotensive therapy was continued based on individual indications throughout the observation period. By day 7, IOP had decreased to Tpalp "N" in all patients and remained stable throughout the follow-up period. Visual acuity in all cases remained unchanged from the preoperative level. Ultrasound biomicroscopy (UBM) revealed that the mean ciliary body thickness (CBT) before surgery was 0.56±0.11 mm. On the first postoperative day, CBT increased by an average of 20.1% due to pronounced edema caused by hydration from the inflammatory response, with a gradual return to baseline by the 1-month follow-up. At 6 months, no statistically significant difference in CBT from the preoperative thickness was observed, with a mean CBT of 0.50±0.12 mm.CONCLUSIONS. Micropulse cyclophotocoagulation can be an effective treatment for secondary glaucoma in patients with post-burn and terminal dystrophic corneal leukomas. This technique reduces the risk of intraoperative and postoperative complications due to its non-invasive nature and low surgical trauma. The procedure can be repeated if IOP increases, and gentle laser parameters can help preserve visual potential.
- Open Access
- 13 November 2024
- Published by Pirogov National Medical and Surgical Center in Bulletin of Pirogov National Medical & Surgical Center
- Vol. 19 (4) , 42-46
RE-DRAIN SURGERY IN PATIENTS WITH REFRACTORY GLAUCOMA
The choice of surgical treatment method for patients with refractory glaucoma of various etiologies is quite complicated. The most commonly performed surgeries are implantation of drainage devices or laser treatment methods. This article presents the results of repeated drainage surgery with Ahmed valve implantation in patients with previously implanted Ex-press shunt in patients with different types of refractory glaucoma.Objective. To present the results of surgical treatment of patients with advanced refractory glaucoma with implantation of Ahmed valve drainage after previous implantation of Ex-Press shunt.Methods. The study included 10 patients (10 eyes) with refractory glaucoma of various etiologies who had previously undergone Ex-Press implantation and subsequently received surgery with Ahmed valve implantation.Results. After surgical treatment, a statistically significant decrease in the level of intraocular pressure was detected in all cases. In the early postoperative period, in one case a choroidal detachment was detected. In the early postoperative period and also during the whole period of follow-up the drainage tube was in the correct position in anterior chamber. By the 6th month of follow-up hypotensive drops were required in 5 patients.Conclusion. At decompensation of intraocular pressure after antiglaucoma surgery with Ex-Press microshunt in patients with refractory glaucoma implantation of Ahmed valve drainage showed efficacy up to 3 years.
- 13 November 2024
- Published by Pirogov National Medical and Surgical Center in Bulletin of Pirogov National Medical & Surgical Center
- Vol. 19 (4) , 42-46
Open AccessRE-DRAIN SURGERY IN PATIENTS WITH REFRACTORY GLAUCOMA
The choice of surgical treatment method for patients with refractory glaucoma of various etiologies is quite complicated. The most commonly performed surgeries are implantation of drainage devices or laser treatment methods. This article presents the results of repeated drainage surgery with Ahmed valve implantation in patients with previously implanted Ex-press shunt in patients with different types of refractory glaucoma.Objective. To present the results of surgical treatment of patients with advanced refractory glaucoma with implantation of Ahmed valve drainage after previous implantation of Ex-Press shunt.Methods. The study included 10 patients (10 eyes) with refractory glaucoma of various etiologies who had previously undergone Ex-Press implantation and subsequently received surgery with Ahmed valve implantation.Results. After surgical treatment, a statistically significant decrease in the level of intraocular pressure was detected in all cases. In the early postoperative period, in one case a choroidal detachment was detected. In the early postoperative period and also during the whole period of follow-up the drainage tube was in the correct position in anterior chamber. By the 6th month of follow-up hypotensive drops were required in 5 patients.Conclusion. At decompensation of intraocular pressure after antiglaucoma surgery with Ex-Press microshunt in patients with refractory glaucoma implantation of Ahmed valve drainage showed efficacy up to 3 years.
- Open Access
- 12 November 2024
- Published by Pirogov National Medical and Surgical Center in Bulletin of Pirogov National Medical & Surgical Center
- Vol. 19 (4) , 25-28
SURGICAL TREATMENT OF CYSTIC FILTRATION BLEBS AFTER SINUSTRABECULECTOMY: CASES FROM PRACTICE
The article presents two similar clinical cases. Patients with complaints of bulbar conjunctiva neoplasm, which grew on the cornea, caused a pronounced feeling of discomfort and partially impaired visual functions, turned to the department of surgical treatment of glaucoma of the MNTC “Eye Microsurgery”. It should be noted that previously these patients underwent a sinustrabeculectomy at their place of residence in order to reduce intraocular pressure. After examination and additional instrumental research methods, the presence of a cystic filtration bleb was diagnosed and the area of anti-glaucoma surgery was revised with individual characteristics in each case. As a result of the treatment, a positive effect was achieved. At a repeat visit a month after surgery, patients did not complain, intraocular pressure was compensated, and there were no relapses.
- 12 November 2024
- Published by Pirogov National Medical and Surgical Center in Bulletin of Pirogov National Medical & Surgical Center
- Vol. 19 (4) , 25-28
Open AccessSURGICAL TREATMENT OF CYSTIC FILTRATION BLEBS AFTER SINUSTRABECULECTOMY: CASES FROM PRACTICE
The article presents two similar clinical cases. Patients with complaints of bulbar conjunctiva neoplasm, which grew on the cornea, caused a pronounced feeling of discomfort and partially impaired visual functions, turned to the department of surgical treatment of glaucoma of the MNTC “Eye Microsurgery”. It should be noted that previously these patients underwent a sinustrabeculectomy at their place of residence in order to reduce intraocular pressure. After examination and additional instrumental research methods, the presence of a cystic filtration bleb was diagnosed and the area of anti-glaucoma surgery was revised with individual characteristics in each case. As a result of the treatment, a positive effect was achieved. At a repeat visit a month after surgery, patients did not complain, intraocular pressure was compensated, and there were no relapses.
- Open Access
- 15 July 2024
- Published by ECO-Vector LLC in Journal of Clinical Practice
- Vol. 15 (2) , 73-80
Surgical treatment of secondary refractory glaucoma in chronic uveitis with corneal dystrophy (clinical case)
BACKGROUND: Uveitis is the inflammation of the iris, ciliary body, vitreous, retina, or vascular membrane, in which the most common complication is a secondary increase in intraocular pressure that is difficult to compensate with antihypertensive drugs. Ahmed valve implantation in uveal glaucoma is an effective surgical method to reduce intraocular pressure. CLINICAL CASE DESCRIPTION: In the Department of Surgical Treatment of Glaucoma of the S. Fyodorov Eye Microsurgery Federal State Institution, Ahmed valve implantation was performed in two patients with refractory, repeatedly operated uveal glaucoma. As a result of valve implantation, in both cases, compensation of intraocular pressure within up to 15 months after surgery was possible. CONCLUSION: Ahmed valve implantation in secondary uveal repeatedly operated glaucoma in patients with chronic uveitis and corneal dystrophy achieved compensation of intraocular pressure and preserved visual functions.
- 15 July 2024
- Published by ECO-Vector LLC in Journal of Clinical Practice
- Vol. 15 (2) , 73-80
Open AccessSurgical treatment of secondary refractory glaucoma in chronic uveitis with corneal dystrophy (clinical case)
BACKGROUND: Uveitis is the inflammation of the iris, ciliary body, vitreous, retina, or vascular membrane, in which the most common complication is a secondary increase in intraocular pressure that is difficult to compensate with antihypertensive drugs. Ahmed valve implantation in uveal glaucoma is an effective surgical method to reduce intraocular pressure. CLINICAL CASE DESCRIPTION: In the Department of Surgical Treatment of Glaucoma of the S. Fyodorov Eye Microsurgery Federal State Institution, Ahmed valve implantation was performed in two patients with refractory, repeatedly operated uveal glaucoma. As a result of valve implantation, in both cases, compensation of intraocular pressure within up to 15 months after surgery was possible. CONCLUSION: Ahmed valve implantation in secondary uveal repeatedly operated glaucoma in patients with chronic uveitis and corneal dystrophy achieved compensation of intraocular pressure and preserved visual functions.
- 12 July 2024
- Published by Mediprint in POINT OF VIEW. EAST – WEST
- Vol. 11 (2)
Laser treatment of secondary angle-closure glaucoma in a patient with ciliary body cysts
Purpose. To present a clinical case of a patient with secondary uncompensated angle-closure glaucoma caused by ciliary body cysts, and to evaluate the effectiveness of treatment using laser iridectomy with cyst puncture and segmental iridoplasty. Material and methods. Patient S., 64 years old, was under observation with a diagnosis of secondary uncompensated angle-closure glaucoma, ciliary body cysts, and initial cataract of the left eye. Laser treatment was performed: under local drip anesthesia, laser iridectomy was performed in the projection of the largest ciliary body cyst with its opening with a YAG laser and segmental iridoplasty around the iris coloboma. Results. In the postoperative period after laser surgery, intraocular pressure was normalized. Biomicroscopy visualized laser colobomas of the iris for 5 hours, traces of lasercoagulates on the surface of the iris. There are no complaints for up to 3 months after surgery, intraocular pressure is compensated with one antihypertensive drug. Conclusion. Laser iridectomy with ciliary body cyst puncture and segmental iridoplasty in secondary angle-closure glaucoma in a patient with ciliary body cysts allowed to achieve compensation of intraocular pressure and preservation of visual functions. Key words: angle-closure glaucoma, ciliary body cysts, intraocular pressure, laser treatment
- 12 July 2024
- Published by Mediprint in POINT OF VIEW. EAST – WEST
- Vol. 11 (2)
Laser treatment of secondary angle-closure glaucoma in a patient with ciliary body cysts
Purpose. To present a clinical case of a patient with secondary uncompensated angle-closure glaucoma caused by ciliary body cysts, and to evaluate the effectiveness of treatment using laser iridectomy with cyst puncture and segmental iridoplasty. Material and methods. Patient S., 64 years old, was under observation with a diagnosis of secondary uncompensated angle-closure glaucoma, ciliary body cysts, and initial cataract of the left eye. Laser treatment was performed: under local drip anesthesia, laser iridectomy was performed in the projection of the largest ciliary body cyst with its opening with a YAG laser and segmental iridoplasty around the iris coloboma. Results. In the postoperative period after laser surgery, intraocular pressure was normalized. Biomicroscopy visualized laser colobomas of the iris for 5 hours, traces of lasercoagulates on the surface of the iris. There are no complaints for up to 3 months after surgery, intraocular pressure is compensated with one antihypertensive drug. Conclusion. Laser iridectomy with ciliary body cyst puncture and segmental iridoplasty in secondary angle-closure glaucoma in a patient with ciliary body cysts allowed to achieve compensation of intraocular pressure and preservation of visual functions. Key words: angle-closure glaucoma, ciliary body cysts, intraocular pressure, laser treatment